Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

BACKGROUND: Compared to angiotensin inhibition, angiotensin-neprilysin “blockade” improves mortality and reduces hospitalizations in patients with heart failure (HF) with reduced ejection fraction (EF). Sacubitril/valsartan is known to influence left ventricular (LV) reverse remodeling with systolic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Cardiol Heart Vasc
Päätekijät: Paolini, Carla, Mugnai, Giacomo, Dalla Valle, Chiara, Volpiana, Andrea, Ferraglia, Alessandra, Frigo, Anna Chiara, Bilato, Claudio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2021
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213880/
https://ncbi.nlm.nih.gov/pubmed/34179333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2021.100821
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia